Mechanistic description
Target DGAT1/DGAT2 inhibition or ATGL activation to restore metabolic homeostasis by addressing lipid metabolism dysfunction unique to APOE4 carriers
Mechanism / pathway
- DGAT1
- neurodegeneration
Evidence for (5)
PubMed PMID 39201759
PubMed PMID 38340721
PubMed PMID 32559414
PubMed PMID 39154689
PubMed PMID 37648867
Evidence against (1)
Evidence matrix
Supporting
- PubMed PMID 39201759 PMID:39201759 · PubMed
- PubMed PMID 38340721 PMID:38340721 · PubMed
- PubMed PMID 32559414 PMID:32559414 · PubMed
- PubMed PMID 39154689 PMID:39154689 · PubMed
- PubMed PMID 37648867 PMID:37648867 · PubMed
Contradicting
No contradicting evidence recorded.
Cite this hypothesis
Cite this hypothesis
etl-backfill (2026). Lipid Droplet Dynamics as Therapeutic Lever. SciDEX hypothesis. https://prism.scidex.ai/hypotheses/hyp-SDA-2026-04-08-gap-debate-20260406-062033-fecb8755-3
@misc{scidex_hypothesis_hypsda20,
title = {Lipid Droplet Dynamics as Therapeutic Lever},
author = {etl-backfill},
year = {2026},
howpublished = {SciDEX hypothesis},
url = {https://prism.scidex.ai/hypotheses/hyp-SDA-2026-04-08-gap-debate-20260406-062033-fecb8755-3},
note = {SciDEX artifact hypothesis:hyp-SDA-2026-04-08-gap-debate-20260406-062033-fecb8755-3}
}